IGC Pharma (IGC) Change in Accured Expenses (2010 - 2025)
IGC Pharma (IGC) reported Change in Accured Expenses of $93000.0 for Q3 2025, down 70.57% year-over-year from $316000.0 in Q3 2024, and up 115.53% quarter-over-quarter from -$599000.0 in Q2 2025.
IGC Pharma (IGC) Change in Accured Expenses (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 13 years of Change in Accured Expenses data on file, last reported at $93000.0 in Q3 2025.
- Change in Accured Expenses for Q3 2025 came in at $93000.0, down 70.57% year-over-year; the trailing twelve-month figure through Sep 2025 was -$1.2 million (down 344.05% YoY), and the FY2026 annual result was -$98000.0, up 50.0% from the prior year.
- Change in Accured Expenses advanced to $93000.0 in Q3 2025 per IGC's latest filing, from -$599000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $484000.0 in Q1 2023 and troughed at -$599000.0 in Q2 2025.
- A 4-year average of -$3714.3 and a median of $59500.0 in 2021 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses surged 236.17% in 2024, then sank 496.69% in 2025.
- A 4-year view of Change in Accured Expenses shows it stood at -$30000.0 in 2021, then slumped by 793.33% to -$268000.0 in 2023, then increased by 19.4% to -$216000.0 in 2024, then jumped by 143.06% to $93000.0 in 2025.
- Business Quant data shows IGC's Change in Accured Expenses at $93000.0 in Q3 2025, -$599000.0 in Q2 2025, and -$447000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Jun 30, 2025 | -599,000.00 |
| Mar 31, 2025 | -447,000.00 |
| Mar 31, 2025 | -447,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Dec 31, 2024 | -216,000.00 |
| Sep 30, 2024 | 316,000.00 |
| Sep 30, 2024 | 316,000.00 |
| Jun 30, 2024 | 151,000.00 |
| Jun 30, 2024 | 151,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | -268,000.00 |
| Dec 31, 2023 | -268,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Sep 30, 2023 | 94,000.00 |
| Jun 30, 2023 | 91,000.00 |
| Jun 30, 2023 | 91,000.00 |